Correlation Between Fluidra and Pharma Mar

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fluidra and Pharma Mar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fluidra and Pharma Mar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fluidra and Pharma Mar SA, you can compare the effects of market volatilities on Fluidra and Pharma Mar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fluidra with a short position of Pharma Mar. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fluidra and Pharma Mar.

Diversification Opportunities for Fluidra and Pharma Mar

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Fluidra and Pharma is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Fluidra and Pharma Mar SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharma Mar SA and Fluidra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fluidra are associated (or correlated) with Pharma Mar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharma Mar SA has no effect on the direction of Fluidra i.e., Fluidra and Pharma Mar go up and down completely randomly.

Pair Corralation between Fluidra and Pharma Mar

Assuming the 90 days trading horizon Fluidra is expected to under-perform the Pharma Mar. But the stock apears to be less risky and, when comparing its historical volatility, Fluidra is 1.75 times less risky than Pharma Mar. The stock trades about -0.03 of its potential returns per unit of risk. The Pharma Mar SA is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  7,690  in Pharma Mar SA on December 30, 2024 and sell it today you would earn a total of  630.00  from holding Pharma Mar SA or generate 8.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Fluidra  vs.  Pharma Mar SA

 Performance 
       Timeline  
Fluidra 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Fluidra has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Fluidra is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Pharma Mar SA 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pharma Mar SA are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Pharma Mar may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Fluidra and Pharma Mar Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fluidra and Pharma Mar

The main advantage of trading using opposite Fluidra and Pharma Mar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fluidra position performs unexpectedly, Pharma Mar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma Mar will offset losses from the drop in Pharma Mar's long position.
The idea behind Fluidra and Pharma Mar SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance